相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Targeted therapy in patients with PIK3CA-related overgrowth syndrome
Quitterie Venot et al.
NATURE (2018)
Molecular diagnosis of PIK3CA-related overgrowth spectrum (PROS) in 162 patients and recommendations for genetic testing
Paul Kuentz et al.
GENETICS IN MEDICINE (2017)
Efficacy and Safety of Mammalian Target of Rapamycin Inhibitors in Vascular Anomalies: A Systematic Review
Marion Nadal et al.
ACTA DERMATO-VENEREOLOGICA (2016)
Efficacy and Safety of Sirolimus in the Treatment of Complicated Vascular Anomalies
Denise M. Adams et al.
PEDIATRICS (2016)
Rapamycin improves TIE2-mutated venous malformation in murine model and human subjects
Elisa Boscolo et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Phosphoinositide 3-kinase-related overgrowth: cellular phenotype and future therapeutic options
Victoria E R Parker et al.
LANCET (2015)
Molecular and Functional Characterization of Three Different Postzygotic Mutations in PIK3CA-Related Overgrowth Spectrum (PROS) Patients: Effects on PI3K/AKT/mTOR Signaling and Sensitivity to PIK3 Inhibitors
Daria C. Loconte et al.
PLOS ONE (2015)
Clinical delineation and natural history of the PIK3CA-related overgrowth spectrum
Kim M. Keppler-Noreuil et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2014)
Somatic gain-of-function mutations in PIK3CA in patients with macrodactyly
Jonathan J. Rios et al.
HUMAN MOLECULAR GENETICS (2013)
Macrodactyly - options and outcomes
J. Hardwicke et al.
JOURNAL OF HAND SURGERY-EUROPEAN VOLUME (2013)
mTORC1 Inhibition Is Required for Sensitivity to PI3K p110α Inhibitors in PIK3CA-Mutant Breast Cancer
Moshe Elkabets et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Population Pharmacokinetics of Sirolimus in Pediatric Patients With Neurofibromatosis Type 1
Jeffrey R. Scott et al.
THERAPEUTIC DRUG MONITORING (2013)
Somatic Mosaic Activating Mutations in PIK3CA Cause CLOVES Syndrome
Kyle C. Kurek et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2012)
Mosaic overgrowth with fibroadipose hyperplasia is caused by somatic activating mutations in PIK3CA
Marjorie J. Lindhurst et al.
NATURE GENETICS (2012)
De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromes
Jean-Baptiste Riviere et al.
NATURE GENETICS (2012)
PI3K signalling: the path to discovery and understanding
Bart Vanhaesebroeck et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2012)
Sirolimus for the Treatment of Complicated Vascular Anomalies in Children
Adrienne M. Hammill et al.
PEDIATRIC BLOOD & CANCER (2011)
Everolimus for Subependymal Giant-Cell Astrocytomas in Tuberous Sclerosis.
Darcy A. Krueger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
The PedsQL in pediatric cerebral palsy: reliability, validity, and sensitivity of the Generic Core Scales and Cerebral Palsy Module
James W. Varni et al.
DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY (2006)
The World Health Organization's WHOQOL-BREF quality of life assessment: Psychometric properties and results of the international field trial - A report from the WHOQOL group
SM Skevington et al.
QUALITY OF LIFE RESEARCH (2004)
PedsQL™ 4.0:: Reliability and validity of the pediatric quality of life Inventory™ Version 4.0 generic core scales in healthy and patient populations
JW Varni et al.
MEDICAL CARE (2001)
分享论文
